Navigation Links
Renaissance Health Publishing, LLC Asks Key Credibility Questions of ConsumerLab.com
Date:12/4/2007

BOCA RATON, Fla., Dec. 4 /PRNewswire/ --ConsumerLab.com, LLC claims to be a leading provider of independent test results and information to help consumers and healthcare professionals evaluate health, wellness, and nutrition products. But Renaissance Health Publishing, LLC -- the makers of Revatrol, a red-wine 100MG resveratrol supplement -- is confused and disappointed as to why a recent study by ConsumerLab.com on red wine supplements analyzed a formulation of Revatrol that has been out-of-date for months.

"Not only did they test an obsolete formulation, but Dr. Tod Cooperman of ConsumerLab.com publicly disparaged our product. He insisted our product name implied that it contained resveratrol, but that according to their analysis it contains very little. Dr. Cooperman's statement was an outright misrepresentation," says James DiGeorgia CEO of Renaissance Health Publishing, LLC.

The truth about Revatrol, which ConsumerLab.com would have determined had it exercised adequate due-diligence and tested the current formulation, is that Revatrol contains:
-- 100MG of Actual Resveratrol

-- 100MG Alpha Lipoic Acid

-- 100MG Acetyl-L-Carnitine

-- 100MG Quercetin

According to Renaissance Health, two weeks ago they called on the for- profit laboratory to remove the information ConsumerLab.com currently portrays for Revatrol from its study, and to retest Revatrol's current product, which has been on the market for more than nine (9) months. ConsumerLab.com instead added a notation saying the formulation tested was discontinued.

In the course of Renaissance Health's investigation into this matter and into ConsumerLab.com, they've posed questions that Dr. Tod Cooperman, M.D., president of ConsumerLab.com, LLC, has simply ignored.

"We believe that any organization claiming or implying to be an independent consumer advocate should have no problem answering the basic and simple questions we've asked," says DiGeorgi
'/>"/>

SOURCE Renaissance Health Publishing, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...discharged from hospitals on ventilator support an...ths later. Researchers from the Frances Payne Bol...ersity report these findings in American Journal ... only important outcome for patients," says Barbar...utes of Health-funded study, "Composite Outcomes o...
(Date:12/3/2009)...nd other healthcare professionals specialising in ...rt advice to guide them through the complex clinic...demic. , The paper, published online by the Am...m to stay alert to the significant concerns that s...ibly even bird flu (H5N1), to develop into a strai...
(Date:12/3/2009)...ected volunteers from virus linked to cervical can...s) -- The human papillomavirus (HPV) vaccine Cerva...six years, new research has found. , The vaccin...HPV-18) most commonly associated with cervical can...ed 15 to 25, with a normal cervical profile and no...
(Date:12/3/2009)...sive users also feel depressed or anxious when not...News) -- A survey of Chinese adolescents found tha... as likely to harm themselves as other teens. ,...ere living in the Chinese city of Guangzhou in Gua...ey had harmed themselves in some way within the pr...
(Date:12/3/2009)... The Arthritis Foundation bestowed it...ecipients during its national meeting in Atlanta. ...9 -- The Arthritis Foundation bestowed its highest... during its national meeting on Nov. 20 in Atlanta...rding Award for Distinguished Service ,The Arthrit...
Breaking Medicine News(10 mins):Health News:CWRU researchers report poor outcomes for CCI patients leaving hospitals on ventilators 2Health News:Transplant infectious disease experts provide pandemic guidance 2Health News:Transplant infectious disease experts provide pandemic guidance 3Health News:Cervarix Proves Effective Against HPV for Over 6 Years 2Health News:Teen Internet Addicts More Likely to Self-Harm: Study 2Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4
... Increases Serum Sodium Levels Through Increase in...J., May 21 Otsuka Pharmaceutical Co., Ltd. (OPC) ...alization, Inc. (OPDC) announced today that the U....nts with clinically significant hypervolemic and e...
...la Join effort to Link Services, Caseworkers , , ...n,s Policy, Practice and Research at the Universi...th Montgomery County, Pa., Stewards of Change, Mic...eaking interoperable, real-time technology system ...
...g and Financing Offerings Help Healthcare Provider...bursement Deadlines , , PLANO, Texas, May 21 Pe...tsystems.com ) today announced the availability o...cause of the American Recovery and Reinvestment Ac...
...., May 21: Managed Health Care Associates, Inc. (M... is pleased to announce that Kimberly Binaso-Stwal...American Society of Health-System Pharmacists (ASH...esignated Fellows of ASHP, will be honored during ...
...By combining the expertise of its management liabi...as developed enhanced management liability coverag...hcare organizations, including hospitals, long ter...icy and protects healthcare organizations against ...
...This year 28 students in 17 states have won awards... by the Centers for Disease Control and Prevention... the contest invites fifth- and sixth-grade studen... of the winning posters are at www.fightthebitec...
Other Medicine News:Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 2Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 3Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 4Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 5Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 6Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 7Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 8Health News:FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia 9Health News:University of Pennsylvania, Montgomery County Partner on Integrated, Interoperable System Design for Child Welfare 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 2Health News:MHA Clinical Director Kimberly Binaso, Pharm.D. Awarded 2009 ASHP Fellow 3Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 2Health News:Beazley's New Management Liability Coverage is Tailored to Unique Needs of Healthcare Organizations 3Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3
(Date:12/3/2009)... , , SEATTLE and BANGALORE, ...es, a leading provider of software product and app... strategic partnership with,Microsoft BioIT Allian...s.,This will allow players in this rapidly evolvin... development capability, domain knowledge and best...
(Date:12/3/2009)... , , HELSINKI, December 3 /...,and medically proven success in their field, Ligh...cal approval to begin selecting and gene testing,s...e treatment for what the,World Health Organisation...ating and obesity. , A Phase II trial for...
(Date:12/2/2009)... , , NEW YORK, Dec. 2 /PRNewswire/...esearch report is available in its catalogue: ,...tp://www.reportlinker.com/p0164303/Arthroscopes---...opic procedures are on rise, owing to their mounti...of ankles, elbow, wrists, and hips, apart from kne...
Breaking Medicine Technology:Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 2Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 3Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 4Lightlake Therapeutics Inc Receives Ethical Approval to Begin Subject Selection for Future Phase II Clinical Trial for New Obesity Drug, in Helsinki, Finland 5Reportlinker Adds Arthroscopes - A World Market Review 2Reportlinker Adds Arthroscopes - A World Market Review 3Reportlinker Adds Arthroscopes - A World Market Review 4Reportlinker Adds Arthroscopes - A World Market Review 5Reportlinker Adds Arthroscopes - A World Market Review 6Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 1Pennsylvania Department of Health Releases H1N1 Flu Prevention Music Video 61741 2New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 1New Reid Bill Funds Abortion 3A Excludes Bipartisan Stupak Pitts Amendment 61737 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 1Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS Neutral Solutions Through Mutual Channel Partner Data Distributing 6414 4
Replacement Handle
Replacement Needle Tip
Needle and Gouge Spud Set
Storz Corneal Burr
Medicine Products: